GeneWEAVE

GeneWeave Biosciences specializes in developing advanced diagnostic solutions to enhance clinical microbiology and address the challenges posed by drug-resistant infections. The company aims to support hospitals and physicians globally by enabling improved antibiotic stewardship and providing rapid determinations of optimal antibiotic therapy for critical bacterial infections. Utilizing its proprietary Smarticles™ technology, GeneWeave delivers homogeneous assays that can quickly measure bacterial drug resistance without the need for enrichment, culture, or extensive sample preparation, thereby streamlining the diagnostic process and contributing to better patient outcomes.